Protect Pharmaceutical Stock Performance
| PRTT Stock | USD 0.91 0.03 3.41% |
The company holds a Beta of 2.08, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Protect Pharmaceutical will likely underperform. At this point, Protect Pharmaceutical has a negative expected return of -0.7%. Please make sure to check Protect Pharmaceutical's treynor ratio, accumulation distribution, as well as the relationship between the Accumulation Distribution and price action indicator , to decide if Protect Pharmaceutical performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Protect Pharmaceutical has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors. ...more
Protect |
Protect Pharmaceutical Relative Risk vs. Return Landscape
If you would invest 220.00 in Protect Pharmaceutical on August 25, 2024 and sell it today you would lose (129.00) from holding Protect Pharmaceutical or give up 58.64% of portfolio value over 90 days. Protect Pharmaceutical is currently does not generate positive expected returns and assumes 12.3018% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than Protect, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Protect Pharmaceutical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Protect Pharmaceutical's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Protect Pharmaceutical, and traders can use it to determine the average amount a Protect Pharmaceutical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0565
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | PRTT |
Estimated Market Risk
| 12.3 actual daily | 96 96% of assets are less volatile |
Expected Return
| -0.7 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.06 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Protect Pharmaceutical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Protect Pharmaceutical by adding Protect Pharmaceutical to a well-diversified portfolio.
Protect Pharmaceutical Fundamentals Growth
Protect Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Protect Pharmaceutical, and Protect Pharmaceutical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Protect Pink Sheet performance.
| Current Valuation | 2.6 M | |||
| Shares Outstanding | 1.11 M | |||
| Price To Earning | (23.96) X | |||
| EBITDA | (115.4 K) | |||
| Cash And Equivalents | 20.07 K | |||
| Total Debt | 101 K | |||
| Book Value Per Share | (0.01) X | |||
| Earnings Per Share | (0.02) X | |||
| Retained Earnings | (9.37 M) | |||
| Current Liabilities | 33 K | |||
About Protect Pharmaceutical Performance
Assessing Protect Pharmaceutical's fundamental ratios provides investors with valuable insights into Protect Pharmaceutical's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Protect Pharmaceutical is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Protect Pharmaceutical Corporation primarily focuses on crop farming and agricultural businesses. Protect Pharmaceutical Corporation was founded in 1987 and is based in Las Vegas, Nevada. Protect Pharmaceutical is traded on OTC Exchange in the United States.Things to note about Protect Pharmaceutical performance evaluation
Checking the ongoing alerts about Protect Pharmaceutical for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Protect Pharmaceutical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Protect Pharmaceutical generated a negative expected return over the last 90 days | |
| Protect Pharmaceutical has high historical volatility and very poor performance | |
| Protect Pharmaceutical has some characteristics of a very speculative penny stock | |
| Protect Pharmaceutical currently holds 101 K in liabilities. Protect Pharmaceutical has a current ratio of 0.39, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Protect Pharmaceutical until it has trouble settling it off, either with new capital or with free cash flow. So, Protect Pharmaceutical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Protect Pharmaceutical sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Protect to invest in growth at high rates of return. When we think about Protect Pharmaceutical's use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (122.61 K) with profit before overhead, payroll, taxes, and interest of 0. | |
| About 84.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing Protect Pharmaceutical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Protect Pharmaceutical's stock is overvalued or undervalued compared to its peers.
- Examining Protect Pharmaceutical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Protect Pharmaceutical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Protect Pharmaceutical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Protect Pharmaceutical's pink sheet. These opinions can provide insight into Protect Pharmaceutical's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Protect Pink Sheet Analysis
When running Protect Pharmaceutical's price analysis, check to measure Protect Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Protect Pharmaceutical is operating at the current time. Most of Protect Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Protect Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Protect Pharmaceutical's price. Additionally, you may evaluate how the addition of Protect Pharmaceutical to your portfolios can decrease your overall portfolio volatility.